| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1515/REVNEURO.2001.12.1.69 |
| P698 | PubMed publication ID | 11236066 |
| P2093 | author name string | Latchman DS | |
| Coffin RS | |||
| P2860 | cites work | Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse | Q34308944 |
| Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the 'a' sequence | Q34779144 | ||
| Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. | Q36561684 | ||
| Herpes simplex virus Vmw65-octamer binding protein interaction: a paradigm for combinatorial control of transcription | Q38310979 | ||
| Bcl-2 transcription from the proximal P2 promoter is activated in neuronal cells by the Brn-3a POU family transcription factor | Q38336118 | ||
| An inquiry into the mechanisms of herpes simplex virus latency | Q39159400 | ||
| Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease | Q39519102 | ||
| Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system | Q39591444 | ||
| High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5. | Q40954651 | ||
| Protection of neuronal cells from apoptosis by Hsp27 delivered with a herpes simplex virus-based vector | Q40973614 | ||
| Gene transfer to neurons using herpes simplex virus-based vectors | Q41132657 | ||
| Prospects for gene therapy in Parkinson's disease | Q41159915 | ||
| Biology of glial cell line-derived neurotrophic factor (GDNF): implications for the use of GDNF to treat Parkinson's disease | Q41169846 | ||
| Therapeutic potentials for glial cell line-derived neurotrophic factor (GDNF) based upon pharmacological activities in the CNS. | Q41186665 | ||
| Fetal nigral transplantation as a therapy for Parkinson's disease | Q41367101 | ||
| Potential use of herpes simplex virus (HSV) vectors for gene therapy of neurological disorders | Q41543685 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase | Q43185222 | ||
| Pathways of viral gene expression during acute neuronal infection with HSV-1 | Q44933537 | ||
| Intracerebral recombinant HSV-1 vector does not reactivate latent HSV-1. | Q45885582 | ||
| A latent, nonpathogenic HSV-1-derived vector stably expresses beta-galactosidase in mouse neurons | Q46135759 | ||
| Induction of midbrain dopaminergic neurons by Sonic hedgehog | Q46258125 | ||
| Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce l-dopa | Q46578408 | ||
| Decreased reporter gene expression during latent infection with HSV LAT promoter constructs. | Q54647282 | ||
| P433 | issue | 1 | |
| P921 | main subject | gene therapy | Q213901 |
| vector-borne disease | Q2083837 | ||
| Parkinson's disease | Q11085 | ||
| P304 | page(s) | 69-78 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Reviews in the Neurosciences | Q15750651 |
| P1476 | title | Viral vectors for gene therapy in Parkinson's disease | |
| P478 | volume | 12 |
| Q34953242 | Clinical neurotransplantation: core assessment protocol rather than sham surgery as control |
| Q33627771 | Current Experimental Studies of Gene Therapy in Parkinson's Disease |
| Q45122755 | Functional applications of novel Semliki Forest virus vectors are limited by vector toxicity in cultures of primary neurons in vitro and in the substantia nigra in vivo |
| Q45081316 | Gene transfer to the cerebellum |
| Q45867822 | Gene transfer to the rhesus monkey brain using SV40-derived vectors is durable and safe |
| Q45862705 | Inhibiting AIDS in the central nervous system: gene delivery to protect neurons from HIV. |
| Q33985663 | Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders |
| Q34769911 | Potential new methods for antiepileptic drug delivery |
| Q45884593 | Prospects and problems of gene therapy: an update |
| Q34657608 | Stem cells in the treatment of Parkinson's disease. |
| Q45867412 | Strategies for CNS-directed gene delivery: in vivo gene transfer to the brain using SV40-derived vectors |
Search more.